Even though Cantor’s William Tanner slices his price target, he nonetheless angles for almost 115% whopping upside potential for AGRX shares.
Monday turned out to be a nightmare for PhaseRx Inc (NASDAQ:PZRX) investors after the biopharmaceutical firm announced that it has filed for Chapter …
H.C.
